SRPL2024-07-012024-09-30 SRPL2024-07-012024-09-30 SRPL2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member SRPL2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member SRPL2024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 123456 SRPL NOTLISTED Shree Ram Proteins Limited Equity 2024-04-01 2025-03-31 2024-11-14 2024-11-07 INR Lakhs Half yearly 15:30:00 16:00:00 2024-11-14 2024-11-14 true Cash Flow Indirect Not applicable Single segment Solvent Products 2024-07-01 2024-09-30 Unaudited Standalone 0.00 25047000.00 25047000.00 0.00 0.00 103901000.00 1599000.00 33849000.00 284000.00 1374000.00 141007000.00 -115960000.00 0.00 -115960000.00 0.00 0.00 0.00 0.00 -115960000.00 0.00 0.00 0.00 0.00 -115960000.00 7000.00 -115953000.00 0.00 0.00 214200000.00 10 -0.54 -0.54 -0.54 -0.54 -1.08 -1.08 Notes to the financial results: 1. The Company's unaudited financial results for the quarter and half year ended September 30, 2024 have been reviewed by the Audit Committee and subsequently approved & taken on record by the Board of Directors of the Company at its meeting held on 14th November, 2024. 2. The Unaudited financial results for the quarter/half year ended September 30, 2024 have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards 34 Interim Financial Reporting ( Ind AS 34 ) prescribed under section 133 of The Companies Act, 2013 and other recognised accounting practices and the policies to the extend applicable. 3. Figures of previous reporting periods have been regrouped/reclassified wherever necessary to correspond with the figures of the current reporting period. 4. The Statement of Assets and Liabilities as at September 30, 2024 is provided as an Annexure to this Statement. 5. Pursuant to insertion of new clause under Regulation 33, sub-regulation (3), the Company has prepared statement of cash flows for the half year ended September 30, 2024. 6. During the year, the Company on 19 May 2023 ( Record Date ), sub-divided/split of existing Equity Shares of the Company from 1(One) Equity Share having face value of Rs.10/-(Rupees Ten Only) each fully paid up, into 10 (Ten) Equity Share of the face value of Rs.1/- (One) each fully paid up. Accordingly, earnings per share of comparative periods presented has been calculated based on number of shares outstanding in respective periods, as increased by sub-divided/split The Company is currently in the process of raising additional funds for its business operations. 7. The Company is currently facing a shortage of working capital due to an increase in the working capital cycle of the Company and is in default of its covenants on its bank loans and has not paid various statutory dues to the government. 8. The Corporate Insolvency Resolution Process (CIRP) proceeding has been initiated against the Company by NCLT, Ahmedabad bench with effect from 11.01.2023 under the provision of The Insolvency and Bankruptcy Code, 2016 for non payment of amount to one of the company's creditor. However, stay has been granted by National Company Law Appellate Tribunal Principal Bench, New Delhi, as on 25.01.2023 against above proceeding and ordered to pay amount of Rs. 1,21,82,419/- within two weeks of the order in the name of The Pay and Accounts Officer, Ministry of Corporate Affairs, New Delhi . This proceeding has been resolved via settlement agreement dated 09/05/2024 between both the parties and same has been considered by the NCLT Principal Bench, New Delhi in their order dated 02/07/2024. 9. The Company's Operations fall under a single segment Solvent Products . Hence, segment reporting is not applicable as per Indian Accounting Standard (AS) - 108 Operating Segments. 10. Other Income represents loan payable to director being written off by the Company of Rs. 250.47 lacs (PY Rs. nil). 11. Loss in current reporting period is on account of inventory written off by the Company amounting to Rs. 1039.01 lacs (PY Rs. nil). Single segment 2024-04-01 2024-09-30 Unaudited Standalone 0.00 25047000.00 25047000.00 0.00 0.00 103901000.00 1743000.00 33849000.00 1958000.00 3737000.00 145188000.00 -120141000.00 0.00 -120141000.00 0.00 841000.00 841000.00 0.00 -120982000.00 0.00 0.00 0.00 0.00 -120982000.00 14000.00 -120968000.00 0.00 0.00 214200000.00 10 -0.56 0.00 -0.56 -0.56 -1.12 -0.56 Other Expenses 1374000.00 Other Expenses 3737000.00 53736000.00 0.00 0.00 0.00 0.00 0.00 3536000.00 2414000.00 59686000.00 255047000.00 0.00 236495000.00 338000.00 0.00 0.00 236833000.00 323271000.00 815151000.00 874837000.00 214200000.00 129742000.00 343942000.00 343942000.00 105751000.00 105751000.00 1387000.00 107138000.00 272660000.00 100059000.00 10509000.00 383228000.00 2286000.00 1887000.00 36356000.00 423757000.00 530895000.00 874837000.00 33849000.00 103901000.00 700000.00 0.00 -239000.00 0.00 0.00 0.00 0.00 4045000.00 0.00 0.00 0.00 1958000.00 0.00 -70000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 144144000.00 24003000.00 0.00 0.00 197000.00 0.00 0.00 24200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9017000.00 0.00 0.00 0.00 0.00 33849000.00 0.00 0.00 -24832000.00 -632000.00 0.00 -632000.00 970000.00 338000.00